<p>*<b>Student's t-test for difference between mean values, Chi-squared test for differences in proportions.</b></p
<p>Characteristics of patients included in the analysis of recurrences (N = 303 on first admission)....
<p>Abbreviation: n/a, not applicable.</p>a<p>all non-participants vs. all participants; p-values cal...
Characteristics of relapsing-remitting MS cases and controls, and count of CD4+ and CD8+ T cell samp...
<p>*<b>Student's t-test for difference between mean values, Chi-squared test for differences in prop...
<p>Characteristics of relapsed or refractory patients at diagnosis of relapse or refractory disease....
<p>*adjusted for age, sex, year, treatment centre and all variables in table.</p><p>**excluding pati...
Clinical characteristics of 80 patients in RLV and non-RLV groups who had achieved remission at 6 mo...
Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N =...
<p><sup>a</sup> The remaining data were missing or incorrectly coded in the database.</p><p><sup>b</...
<p>ARR: annualized relapse rate; EDSS: expanded disability status scale</p><p>Clinical characteristi...
<p>Clinical characteristics of the study patients at the time of first recurrence.</p
<p>Characteristics at relapse according to method of detection in relapsed aNHL patients after CR1.<...
<p>RR: relapsing-remitting MS; SP: Secondary progressive MS; PP: Primary progressive MS; EDSS: Expan...
<p>Clinical and laboratory characteristics of VL and non-VL cases, among 213 patients with clinical ...
<p>*for definition, see ref <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.00...
<p>Characteristics of patients included in the analysis of recurrences (N = 303 on first admission)....
<p>Abbreviation: n/a, not applicable.</p>a<p>all non-participants vs. all participants; p-values cal...
Characteristics of relapsing-remitting MS cases and controls, and count of CD4+ and CD8+ T cell samp...
<p>*<b>Student's t-test for difference between mean values, Chi-squared test for differences in prop...
<p>Characteristics of relapsed or refractory patients at diagnosis of relapse or refractory disease....
<p>*adjusted for age, sex, year, treatment centre and all variables in table.</p><p>**excluding pati...
Clinical characteristics of 80 patients in RLV and non-RLV groups who had achieved remission at 6 mo...
Univariate analyses of factors associated with VL relapse by 6 months, complete case population (N =...
<p><sup>a</sup> The remaining data were missing or incorrectly coded in the database.</p><p><sup>b</...
<p>ARR: annualized relapse rate; EDSS: expanded disability status scale</p><p>Clinical characteristi...
<p>Clinical characteristics of the study patients at the time of first recurrence.</p
<p>Characteristics at relapse according to method of detection in relapsed aNHL patients after CR1.<...
<p>RR: relapsing-remitting MS; SP: Secondary progressive MS; PP: Primary progressive MS; EDSS: Expan...
<p>Clinical and laboratory characteristics of VL and non-VL cases, among 213 patients with clinical ...
<p>*for definition, see ref <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.00...
<p>Characteristics of patients included in the analysis of recurrences (N = 303 on first admission)....
<p>Abbreviation: n/a, not applicable.</p>a<p>all non-participants vs. all participants; p-values cal...
Characteristics of relapsing-remitting MS cases and controls, and count of CD4+ and CD8+ T cell samp...